Air India pilot undergoes drug test after A320 plunges 300 feet, injuring 17

Summary

An Air India Airbus A320 lost 91 metres of altitude during severe turbulence on a Phuket–Delhi flight on August 4, 2026, injuring 17 passengers and crew. The pilot-in-command’s post-flight drug screening flagged a result now undergoing confirmatory analysis, India’s civil aviation ministry confirmed, as both pilots were grounded and the event classified a Serious Incident.

The investigation follows the June 2025 crash of Air India Flight 171 that killed 260 people, sharply heightening scrutiny on the carrier’s safety culture just days after a new CEO took charge. Confirmatory test results are expected within weeks, while the AAIB has opened its own independent probe.

When an Air India narrow-body plunged 91 metres mid-cruise over the Bay of Bengal, the immediate fallout was 13 passengers and four crew members hospitalised in Delhi. But what will linger far beyond those injuries is the disclosure that the captain’s mandatory post-incident drug screening indicated a result requiring further analysis — an unsettling signal for any airline, and especially for one rebuilding trust after its deadliest disaster in decades.

The August 9, 2026 statement from India’s civil aviation ministry laid out the bare facts: the Airbus A320 operating the Phuket–Delhi service landed safely, all injured are now stable, and a designated laboratory is performing confirmatory testing on the pilot-in-command’s sample. The ministry classified the turbulence encounter as a Serious Incident, triggering a dual investigation by the Directorate General of Civil Aviation (DGCA) — which now holds the cockpit voice and flight data recorders — and the independent Aircraft Accident Investigation Bureau (AAIB).

Both pilots were immediately removed from the flying roster pending results.

The episode lands during an exceptionally fragile period for the carrier. The June 2025 crash of Flight 171, a Boeing 787 that went down shortly after take-off from Ahmedabad, killed 260 people and remains a raw wound in India’s aviation landscape. On August 5, just one day after the turbulence event, Air India appointed former Ethiopian Airlines chief Tewolde Gebremariam as CEO — a seasoned hire meant to stabilise operations and restore credibility. For Gebremariam, the pending drug-test result will be an immediate test of how swiftly his leadership can project control over crew governance.

The details

India’s civil aviation ministry confirmed on August 9 that the pilot-in-command’s psychoactive substance screening “indicated a result requiring confirmatory testing,” with samples sent to a designated laboratory. The final report is pending. The DGCA retrieved the aircraft’s cockpit voice recorder and flight data recorder, while the AAIB launched its own parallel investigation. Air India stated it had not yet received the test results and could not comment on any findings.

The Phuket–Delhi service carried 137 passengers and eight crew members. Most injured passengers were discharged within hours; four cabin crew remained hospitalised through August 5. Union Civil Aviation Minister Ram Mohan Naidu visited those injured and coordinated support with ministry officials, while the airline confirmed both pilots were removed from duty.

The value-add

For premium travellers accustomed to assessing airlines on cabin product and service, the real differentiator here is institutional trust. Air India’s long-haul business- and first-class customers depend on regulatory confidence as much as seat comfort, and a live safety probe can overshadow operational turnaround stories. The carrier’s new CEO, Tewolde Gebremariam, took office with a mandate to rebuild credibility after the Flight 171 tragedy; how quickly his team communicates the confirmatory result and any follow-up actions will set the tone for aviation partners and corporate accounts.

The India–Southeast Asia corridor, where Air India competes with Gulf and Southeast Asian network carriers, is particularly sensitive. Even without a formal route suspension, a protracted investigation can push corporate travel managers and loyalty members toward alternative carriers on the same city pairs. The absence of immediate schedule changes doesn’t mean the reputational risk is contained.

What the pending drug test means for Air India’s safety credibility

A confirmed positive screening would harden regulator scrutiny and could prompt codeshare partners to review safety commitments, particularly for routes connecting through Delhi. Over the next three to twelve months, Air India must demonstrate tighter crew governance, faster disclosure, and cleaner oversight after Flight 171 to reassure corporate buyers and premium cabin passengers. Watch for the laboratory result and the AAIB’s preliminary findings — together they will determine whether this incident becomes a footnote or a turning point in the carrier’s rehabilitation.

FAQ